Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XE3D | ISIN: IE00BJMZDW83 | Ticker-Symbol: DHG
Frankfurt
17.01.25
08:03 Uhr
4,745 Euro
-0,050
-1,04 %
Branche
Hotels/Tourismus
Aktienmarkt
ISEQ-20
1-Jahres-Chart
DALATA HOTEL GROUP PLC Chart 1 Jahr
5-Tage-Chart
DALATA HOTEL GROUP PLC 5-Tage-Chart
RealtimeGeldBriefZeit
4,6204,93518.01.
Dow Jones News
203 Leser
Artikel bewerten:
(1)

Dalata Hotel Group PLC: HOL-Holding(s) in Company

Finanznachrichten News

DJ Dalata Hotel Group PLC: HOL-Holding(s) in Company*

Dalata Hotel Group PLC (DAL,DHG) 
Dalata Hotel Group PLC: HOL-Holding(s) in Company* 
15-Jan-2025 / 13:58 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
Standard Form TR-1 
Standard form for notification of major holdings 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)i 
 
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Dalata 
Hotel Group plc 
 
2. Reason for the notification (please tick the appropriate box or boxes): 
[X] An acquisition or disposal of voting rights 
[ ] An acquisition or disposal of financial instruments 
[ ] An event changing the breakdown of voting rights 
[ ] Other (please specify)iii: 
 
3. Details of person subject to the notification obligationiv: 
                        City and country of registered office (if applicable): 
Name: Janus Henderson Group plc 
                        St Helier, Jersey 
4. Full name of shareholder(s) (if different from 3.)v: 
 
5. Date on which the threshold was crossed or reachedvi: 13 January 2025 
 
6. Date on which issuer notified: 14 January 2025 
 
7. Threshold(s) that is/are crossed or reached: Below 3% 
 
8. Total positions of person(s) subject to the notification obligation: 
                               % of voting rights 
                  % of voting rights    through financial   Total of both Total number of 
                  attached to shares (total instruments      in % (9.A +  voting rights of 
                  of 9.A)          (total of 9.B.1 +   9.B)      issuervii 
                               9.B.2) 
Resulting situation on the date on 
which threshold was crossed or   2.88%           0.00%         2.88%     212,292,232 
reached 
Position of previous notification 3.01%           0.00%         3.01% 
(if applicable) 
 
9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii: 
A: Voting rights attached to shares 
            Number of voting rightsix    % of voting rights 
Class/type of 
shares 
ISIN code (if     Direct       Indirect   Direct            Indirect 
possible) 
 
IE00BJMZDW83               6,119,722                  2.88% 
 
 
SUBTOTAL A       6,119,722            2.88% 
 
B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations 
Type of financial    Expiration Exercise/      Number of voting rights that may be acquired % of voting rights 
instrument        datex   Conversion Periodxi if the instrument is exercised/converted. 
 
 
 
                  SUBTOTAL B.1 
 
B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations 
Type of financial   Expiration  Exercise/  Physical or cash                     % of voting 
instrument       datex    Conversion settlementxii     Number of voting rights      rights 
                  Period xi 
 
 
 
                        SUBTOTAL B.2 
 
10. Information in relation to the person subject to the notification obligation (please tick the applicable box): 
 
[ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not 
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii 
 
[X] Full chain of controlled undertakings through which the voting rights and/or the 
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv: 
 
        % of voting rights if it    % of voting rights through financial    Total of both if it equals 
Namexv     equals or is higher than the  instruments if it equals or is higher than or is higher than the 
        notifiable threshold      the notifiable threshold          notifiable threshold 
Janus Henderson 2.88%             0.00%                    2.88% 
Group plc 
Janus Henderson 
UK (Holdings)  2.88%             0.00%                    2.88% 
Limited 
Janus Henderson 
Investors UK  2.88%             0.00%                    2.88% 
Limited 
 
11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date] 
 
 
 
12. Additional informationxvi: 
 
 
 

Done at 201 Bishopsgate, London EC2M 3AE on 14 January 2025

Annex: Notification of major holdings (only to be filed with the Central Bank of Ireland and not with the relevant 
issuer) 
 
A: Identity of the person subject to the notification obligation 
Full name (including legal form for legal entities) 
Janus Henderson Group plc 
Contact address (registered office for legal entities) 
201 Bishopsgate, London EC2M 3AE 
E-Mail 
HGIThresholdDisclosures@janushenderson.com 
Phone number / Fax number 
+44 207 818 3064 
Other useful information (at least legal a contact person for legal persons) 
John Baker 
 
B: Identity of the notifier, if applicable 
Full name 
 
Contact address 
 
E-Mail 
Phone number / Fax number 
 
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification 
obligation) 
 
 
C: Additional information: 
 
 

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      IE00BJMZDW83, IE00BJMZDW83 
Category Code: HOL 
TIDM:      DAL,DHG 
LEI Code:    635400L2CWET7ONOBJ04 
OAM Categories: 2.3. Major shareholding notifications 
Sequence No.:  370789 
EQS News ID:  2068445 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2068445&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

January 15, 2025 08:59 ET (13:59 GMT)

© 2025 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.